Skip to Content

M 14 (Methotrexate Sodium 2.5 mg)

Pill with imprint M 14 is Orange, Round and has been identified as Methotrexate Sodium 2.5 mg. It is supplied by Mylan Pharmaceuticals Inc..

Methotrexate is used in the treatment of acute lymphocytic leukemia; acute lymphoblastic leukemia; rheumatoid arthritis; breast cancer; juvenile idiopathic arthritis and belongs to the drug classes antimetabolites, antipsoriatics, antirheumatics, other immunosuppressants. Not for use in pregnancy. Methotrexate 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 14

Methotrexate sodium 2.5 mg M 14
Methotrexate sodium 2.5 mg M 14  Front
Methotrexate sodium 2.5 mg M 14  Back
Methotrexate sodium 2.5 mg M 14

Methotrexate Sodium

Imprint:
M 14
Strength:
2.5 mg
Color:
Orange
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Antimetabolites
Antipsoriatics
Antirheumatics
Other immunosuppressants
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC CodeLabeler / Repackager
00378-0014 Mylan Pharmaceuticals Inc.
51079-0670 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide